Global Transdermal Patches Market, By Product (Single-Layer Drug-In-Adhesive, Multi-Layer Drug-In-Adhesive, Matrix, Reservoir, Vapor, and Others), Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, and Others), Application (Cardiovascular Disorder, Central Nervous System Disorders (CNS), Pain Management/ Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Nicotine Cessation, Hormonal Therapy/ Disorders, Dermatology, and Others), Technology (Electric Current, Mechanical Arrays, Thermal Ablation, Chemical Enhancers, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End user (Home Care Settings, Hospitals, and Clinics) – Industry Trends and Forecast to 2031.
Transdermal Patches Market Analysis and Size
In the transdermal patches market within the medical sphere, these patches introduce a transformative approach to drug delivery, leveraging the concept of transdermal administration. Adhering to the skin, they facilitate the controlled release of medications directly into the bloodstream, offering sustained relief and minimized side effects. Widely utilized in pain management, hormone replacement therapy, and nicotine replacement therapy, transdermal patches provide a discreet and convenient alternative to traditional oral medications. Their efficacy extends to preventing motion sickness, managing neurological disorders, and addressing various therapeutic needs, marking a significant advancement in transdermal medical treatments.
Global transdermal patches market size was valued at USD 7.48 billion in 2023 and is projected to reach USD 10.97 billion by 2031, with a CAGR of 4.9% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Single-Layer Drug-In-Adhesive, Multi-Layer Drug-In-Adhesive, Matrix, Reservoir, Vapor, and Others), Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch, Oxybutynin Transdermal Patch, and Others), Application (Cardiovascular Disorder, Central Nervous System Disorders (CNS), Pain Management/ Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Nicotine Cessation, Hormonal Therapy/ Disorders, Dermatology, and Others), Technology (Electric Current, Mechanical Arrays, Thermal Ablation, Chemical Enhancers, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End user (Home Care Settings, Hospitals, and Clinics)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America
|
|
Market Players Covered
|
AdhexPharma (France), ProSolus, Inc (U.S.), tesa SE (Germany), Nitto Denko Corporation. (Japan), Noven Pharmaceuticals, Inc (U.S.), LTS Lohmann Therapie-Systeme AG (Germany), Medherant Limited (U.K.), Corium, LLC. (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Antares Pharma (U.S.), Abbott. (U.S.), Mylan N.V. (U.S.), Acrux Limited (Australia), Sparsha Pharma International Pvt Ltd (India), Bliss GVS Pharma. (India), Johnson & Johnson Services, Inc. (U.S.), Informa Connect Limited (U.K.) among others
|
|
Market Opportunities
|
|
Market Definition
Transdermal patches are adhesive patches applied to the skin to deliver medication through the skin and into the bloodstream over time. They provide a convenient and controlled way of administering drugs, bypassing the digestive system and offering continuous release for sustained therapeutic effects.
Transdermal Patches Market Dynamics
Drivers
- Rising Smoker Population results in Increased Demand for Transdermal Patches
The region's growing smoking population, as evidenced by the CDC's data indicating high usage rates among both high school and middle school students, underscores the escalating demand for smoking cessation aids like nicotine transdermal patches. With approximately 34.0% of high school students and 11.3% of middle school students having used tobacco products, including cigarettes, e-cigarettes, and other variants, there's a pressing need for effective strategies to combat nicotine addiction. Transdermal patches offer a viable solution, providing a discreet and gradual method for delivering nicotine replacement therapy. This surge in demand fueled by the youth demographic contributes significantly to the expansion of the transdermal patches market in the region.
- Increased Prevalence of Cancer Propels the Adoption of Transdermal Patches
The escalating incidence of breast and prostate cancer, as highlighted by reports like GLOBOCAN 2020, notably accelerates the growth trajectory of the transdermal patches market. With Mexico alone projecting a substantial increase in cancer cases over the coming decades, reaching 254,665 new cases by 2030 and 323,432 by 2040, and the demand for innovative drug delivery systems intensifies. Transdermal patches, particularly those containing medication nanoparticles tailored for cancer therapy-related pain management, stand poised to address this growing need. Their non-invasive nature and ability to provide controlled release make them an attractive option for patients grappling with pain associated with cancer treatments, further solidifying their role as a vital component in oncology care, specifically in the domain of transdermal patches for pain.
Opportunities
- Technological Advancements Propel Transdermal Patches to New Levels of Versatility
Innovations in patch design, materials, and drug delivery mechanisms continually enhance the efficacy, safety, and versatility of transdermal patches. These advancements enable the delivery of a broader range of drugs, including those with challenging physicochemical properties, expanding the market's scope across various therapeutic areas. Advancements in manufacturing processes improve scalability and reduce production costs, making transdermal patches more accessible to patients and healthcare providers. As technology evolves, it drives the development of novel patch-based delivery systems, stimulating market expansion and fostering a competitive landscape driven by innovation.
- Rising Healthcare Facility Investments lead to the Adoption of Transdermal Patches
With greater investment, healthcare facilities can afford to adopt and promote innovative drug delivery systems like transdermal patches. These investments enable facilities to enhance their infrastructure, procure advanced medical technologies, and expand their range of treatment options. As healthcare providers strive to improve patient care and outcomes, they increasingly embrace transdermal patches for their convenience and efficacy through improved medication adherence and management of chronic conditions. This growing investment creates a conducive environment for the widespread adoption and utilization of transdermal patches in various healthcare settings, thereby driving market expansion.
Restraints/Challenges
- High Product Cost Limits the Adoption of Transdermal Patches
Compared to conventional oral medications, transdermal patches often entail higher manufacturing expenses due to specialized formulation requirements and the need for precise drug delivery systems. The production of patches with advanced features, such as controlled-release mechanisms, can further increase production costs. These higher manufacturing costs may translate into elevated prices for consumers, potentially limiting their affordability and accessibility, particularly in healthcare systems with budget constraints. Consequently, addressing cost concerns is crucial for ensuring widespread adoption and equitable access to transdermal patches as a viable drug delivery option.
- Skin Irritation Affecting Patient Comfort Limits Transdermal Delivery Systems
Adhesive components or drug formulations in patches may trigger allergic reactions or irritate sensitive skin, limiting their use in specific individuals. This issue necessitates careful consideration of patch materials and formulations to minimize adverse skin reactions. Moreover, skin irritation can lead to discontinuation of treatment and loss of patient confidence in transdermal delivery systems.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2022, Adlarity, developed by Corium, debuted in the U.S. as a prescription medication. This once-weekly transdermal patch delivers consistent doses of donepezil, offering a convenient treatment option for patients with mild, moderate, or severe Alzheimer’s-related dementia. Its innovative delivery system aims to enhance patient compliance and improve therapeutic outcomes
- In 2022, the Luye Pharma Group received approval from China's National Medical Products Administration for their Rivastigmine Twice Weekly Transdermal Patch. This patch, designed for mild to moderate Alzheimer's symptoms, offers a convenient dosing schedule and aims to improve patient adherence. With its innovative transdermal delivery method, it represents a promising addition to Alzheimer's disease management in China
Transdermal Patches Market Scope
The market is segmented on the basis of product, type, application, technology, distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Single-Layer Drug-In-Adhesive
- Multi-Layer Drug-In-Adhesive
- Matrix
- Reservoir
- Vapor
- Others
Type
- Fentanyl Transdermal Patch
- Nicotine Transdermal Patch
- Buprenorphine Transdermal Patch
- Clonidine Transdermal Patch
- Oxybutynin Transdermal Patch
- Others
Application
- Cardiovascular Disorder
- Central Nervous System Disorders (CNS)
- Pain Management/ Relief
- Smoking Reduction and Cessation Aid
- Overactive Bladder
- Nicotine Cessation
- Hormonal Therapy/ Disorders
- Dermatology
- Others
Technology
- Electric Current
- Mechanical Arrays
- Thermal Ablation
- Chemical Enhancers
- Others
Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
End User
- Home Care settings
- Hospitals
- Clinics
Transdermal Patches Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, product, type, application, technology, distribution channel, and end user as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
North America is expected to dominate the market due to the region boasts a robust network of healthcare facilities, facilitating widespread access to treatment. Major players in the pharmaceutical industry have established a significant presence in North America, driving innovation and distribution. Additionally, the region's commitment to research and development in healthcare fuels continuous advancements, further solidifying its dominance in the market. These factors collectively contribute to North America's stronghold in the pharmaceutical landscape.
Asia-Pacific is expected to have substantial growth, driven by various factors. Government initiatives promoting healthcare awareness, coupled with expanding healthcare infrastructure, will catalyze this growth. Increased research activities further contribute to reaching the region's vast undiscovered markets and large population base. Moreover, the rising demand for quality healthcare services underscores the region's potential as a critical player in the global healthcare landscape.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Transdermal Patches Market Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- AdhexPharma (France)
- ProSolus, Inc (U.S.)
- tesa SE (Germany)
- Nitto Denko Corporation. (Japan)
- Noven Pharmaceuticals, Inc (U.S.)
- LTS Lohmann Therapie-Systeme AG (Germany)
- Medherant Limited (U.K.)
- Corium, LLC. (U.S.)
- Bayer AG (Germany)
- Novartis AG (Switzerland)
- Antares Pharma (U.S.)
- Abbott. (U.S.)
- Mylan N.V. (U.S.)
- Acrux Limited (Australia)
- Sparsha Pharma International Pvt Ltd (India)
- Bliss GVS Pharma. (India)
- Johnson & Johnson Services, Inc. (U.S.)
- Informa Connect Limited (U.K.)
SKU-